Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management
The Neurologist 8:227-236, Frohman,E.,et al, 2002
Relapse in Multiple Sclerosis
BMJ 350:h1765, Galea, I.,et al, 2015
Failure to Take Antiepileptic Drugs as Prescribed
Arch Neurol 68:1318-1320, Modur, P.N., 2011
Nonadherence to Antiepileptic Drugs and Increased Mortality: Findings from the RANsom Study
Neurol 71:1572-1578, Faught,E.,et al, 2008
Patients with Refractory Seizures
NEJM 340:1565-1570, Devinsky,O, 1999
Double-Blind Crossover of Tegretol-XR and Tegretol in Patients with Epilepsy
Tegretol OROS Study Grp, Neurol 45:1703-17071995., , 1995
Optimizing Long-Term Patient Compliance
Neurol 45(Suppl 1):S25-S28, Cramer,J.A., 1995
Long-Term Therapeutic Management of Epilepsy
Ann Int Med 120:411-422, French,J., 1994
Status Epilepticus at an Urban Public Hospital in the 1980s
Neurol 43:483-488, Lowenstein,D.H.&Alldredge,B.K., 1993
Comparison of Sprinkle Versus Syrup Formulations of Valproate for Bioavailability, Tolerance, and Preference
J Pediatr 120:634-638, Cloyd,J.C.,et al, 1992
Etiology and Mortality of Status Epilepticus in Children, A Recent Update
Arch Neurol 46:74-76, Phillips,S.A.&Shanahan,R.J., 1989
The Effects of Storage and Shaking on the Settling Properties of Phenytoin Suspension
Neurol 39:207-209, Sarkar,M.A.,et al, 1989
How Often is Medication Taken as Prescribed? A Novel Assessment Technique
JAMA 261:3273-3277, Cramer,J.A.,et al, 1989
Level Off
Neurol 1009-1010, Dodson,W.E., 1989
The Measurement of Anticonvulsant Agent Levels
Ann Int Med 100:854-858, Troupin,A.S., 1984
Status Epilepticus
Am J Med 69:657-665, Aminoff,M.J.,et al, 1980
Compliance in Anticonvulsant Drug Therapy
Epilepsia 16:203, Eisler,J.,et al, 1975
Checking Compliance of Epileptic Patients
NEJM 287:934, Livingston,S., 1972